Plexus price target raised to $150 from $145 at Benchmark

Benchmark analyst David Williams raised the firm’s price target on Plexus to $150 from $145 and keeps a Buy rating on the shares. Plexus continues to execute well with new program win momentum and improving fundamentals, says the firm, which does not anticipate a major change in the company’s trajectory or near-term outlook despite the volatile macro environment.